[Current therapy concepts in patients with multiple myeloma]

Dtsch Med Wochenschr. 2000 Oct 6;125(40):1201-9. doi: 10.1055/s-2000-7695.

[Article in German]

Authors

A Heyll¹, P Schneider, U Bauser, G Kobbe, A Hünerlitürkoglu, C Aul, R Haas

Affiliation

¹ Klinik für Hämatologie Onkologie und klinische Immunologie, Universität Düsseldorf.

PMID: 11075253
DOI: 10.1055/s-2000-7695

No abstract available

Publication types

Comparative Study
Review

MeSH terms

Age Factors
Aged
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Clinical Trials as Topic
Combined Modality Therapy
Diphosphonates / therapeutic use
Erythropoietin / therapeutic use
Humans
Interferons / therapeutic use
Interleukin-2 / therapeutic use
Middle Aged
Multiple Myeloma / drug therapy
Multiple Myeloma / radiotherapy
Multiple Myeloma / therapy*
Plasmacytoma / radiotherapy
Plasmacytoma / therapy
Prospective Studies
Radiotherapy Dosage
Randomized Controlled Trials as Topic
Stem Cell Transplantation
Transplantation, Autologous

Substances

Diphosphonates
Interleukin-2
Erythropoietin
Interferons